Impax Asset Management Group plc cut its holdings in Chemed Corporation (NYSE:CHE – Free Report) by 5.4% in the third quarter, Holdings Channel reports. The institutional investor owned 253,182 shares of the company’s stock after selling 14,407 shares during the quarter. Impax Asset Management Group plc’s holdings in Chemed were worth $113,360,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Krilogy Financial LLC purchased a new position in shares of Chemed in the third quarter worth about $374,000. ProShare Advisors LLC grew its position in shares of Chemed by 33.5% in the third quarter. ProShare Advisors LLC now owns 75,405 shares of the company’s stock valued at $33,762,000 after purchasing an additional 18,901 shares in the last quarter. Oppenheimer & Co. Inc. grew its position in shares of Chemed by 3.1% in the third quarter. Oppenheimer & Co. Inc. now owns 13,101 shares of the company’s stock valued at $5,866,000 after purchasing an additional 392 shares in the last quarter. Fortune Financial Advisors LLC boosted its stake in Chemed by 4.4% during the third quarter. Fortune Financial Advisors LLC now owns 1,673 shares of the company’s stock worth $749,000 after buying an additional 70 shares during the last quarter. Finally, Smartleaf Asset Management LLC increased its stake in shares of Chemed by 71.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after acquiring an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the stock. Royal Bank Of Canada cut their price objective on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $555.50.
Insiders Place Their Bets
In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the transaction, the chief executive officer owned 94,197 shares of the company’s stock, valued at $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 3.29% of the stock is currently owned by company insiders.
Chemed Stock Up 0.8%
Shares of CHE opened at $451.73 on Wednesday. The company has a market cap of $6.40 billion, a P/E ratio of 23.89, a PEG ratio of 2.18 and a beta of 0.44. The firm’s 50 day moving average price is $437.45 and its 200 day moving average price is $441.56. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60.
Chemed Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
See Also
- Five stocks we like better than Chemed
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
